A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase Ⅰ study is to evaluate the safety, tolerability and
pharmacokinetics of HRS-1893 in healthy volunteers and patients with obstructive hypertrophic
cardiomyopathy